News | Radiation Therapy | April 26, 2017

Nine New Disease Sites Added to the NCCN Radiation Therapy Compendium

Compendium provides a single access point for radiation therapy recommendations within 33 NCCN Guidelines

Nine New Disease Sites Added to the NCCN Radiation Therapy Compendium

April 26, 2017 — The National Comprehensive Cancer Network (NCCN) continues to build its NCCN Radiation Therapy Compendium with the publication of radiation therapy (RT) recommendations from an additional nine NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines):

The new guidelines include recommendations for:

  • Acute Lymphoblastic Leukemia, Version 2.2016;
  • Basal Cell Skin Cancer, Version 1.2017;
  • Dermatofibrosarcoma Protuberans, Version 1.2017;
  • Gastric Cancer, Version 1.2017;
  • Hodgkin Lymphoma, Version 1.2017;
  • Merkel Cell Carcinoma, Version 1.2017;
  • Ovarian Cancer, Version 1.2017;
  • Squamous Cell Skin Cancer, Version 1.2017; and
  • Thymomas and Thymic Carcinomas, Version 1.2017.

Launched in March 2017, the NCCN Radiation Therapy Compendium now includes recommendations from 33 NCCN Guidelines. Additional cancer types will be published on a rolling basis over the coming months.

The compendium provides guidance on all RT modalities recommended within the NCCN Guidelines, including:

  • Intensity modulated radiation therapy (IMRT);
  • Intra-operative radiation therapy (IORT);
  • Stereotactic radiosurgery (SRS)/stereotactic body radiotherapy (SBRT)/stereotactic ablative radiotherapy (SABR);
  • Image-guided radiotherapy (IGRT);
  • Low dose-rate brachytherapy (LDR)/High dose-rate brachytherapy (HDR);
  • Radioisotope; and
  • Particle therapy.

Transparency of NCCN Guidelines and Compendia development is central to the philosophy, policies and procedures of NCCN. NCCN posts the policies and processes for developing and maintaining the NCCN Guidelines. These policies are available to the public on the NCCN website. Identification of newly published research, NCCN Member Institution review, external stakeholder submissions and panel review occur on an ongoing basis with at least annual review performed for NCCN Guidelines for each disease.

For more information: www.nccn.org

Related Content

Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case
News | Treatment Planning | March 08, 2019
Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's...